BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 20030418)

  • 1. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine versus other antidepressive agents for depression.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006528. PubMed ID: 22161405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    J Clin Psychiatry; 2008 Sep; 69(9):1404-15. PubMed ID: 19193341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine for fibromyalgia in adults.
    Welsch P; Bernardy K; Derry S; Moore RA; Häuser W
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012708. PubMed ID: 30080242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants for insomnia in adults.
    Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants for the treatment of depression in people with cancer.
    Vita G; Compri B; Matcham F; Barbui C; Ostuzzi G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD011006. PubMed ID: 36999619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine versus other anti-depressive agents for depression.
    Purgato M; Papola D; Gastaldon C; Trespidi C; Magni LR; Rizzo C; Furukawa TA; Watanabe N; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006531. PubMed ID: 24696195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants versus placebo for panic disorder in adults.
    Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine: a review of its use in major depression.
    Holm KJ; Markham A
    Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2008; 22(7):587-602. PubMed ID: 18547127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milnacipran versus other antidepressive agents for depression.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
    Cipriani A; Furukawa TA; Geddes JR; Malvini L; Signoretti A; McGuire H; Churchill R; Nakagawa A; Barbui C;
    J Clin Psychiatry; 2008 Nov; 69(11):1732-42. PubMed ID: 19026250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.